Most physicians said the positives of clozapine's REMS outweighed its negatives. Most also said that mandatory blood testing was necessary, but it created a burden and medication delays. In 2024, an ...
Is a risk evaluation and mitigation strategy (REMS) still needed for clozapine? That's what a joint meeting of two FDA advisory committees will discuss on Tuesday. Risk management requirements for the ...
Clozapine is a schizophrenia drug that can cause constipation. Doctors usually prescribe it when other schizophrenia medications don’t work for you. Keep reading to learn more about constipation ...
Pham is a combined internal medicine and psychiatry resident physician at the Medical College of Wisconsin. When Christen White’s brother had his first psychotic episode thinking Steven Spielberg was ...
US regulators have put some of the new clozapine risk evaluation and mitigation strategy (REMS) program on temporary hold because of start-up difficulties, including long telephone wait times. In a ...
Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies. By Ellen Barry The Food and Drug Administration has taken a crucial step toward ...
To address "continuing safety concerns" about severe neutropenia associated with the atypical antipsychotic clozapine (multiple brands), the US Food and Drug Administration (FDA) is making changes to ...
Schizophrenia can be a difficult-to-manage disease with roughly one-third of all patients developing treatment-resistance (Essali, Al-Haj Hassan, Li, & Rathbone, 2009). While various definitions of ...
Clozapine is the most effective antipsychotic medication (Siskind, McCartney, Goldschlager, & Kisely, 2016; McEvoy et al., 2006) and the only antipsychotic that has been shown to decrease suicide and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results